ArticleThe Journal of biological chemistry2015

Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.

Elisabeth Losdyck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.